Jennifer Adjemian - Concepedia

Author

Jennifer Adjemian

National Institute of Allergy and Infectious Diseases

Also Known As

Adjemian, Jennifer, JENNIFER ADJEMIAN, JENNIFER ZIPSER ADJEMIAN, Jennifer Adjemian, Jennifer Zipser Adjemian, Lung Injury Response Epidemiology/Surveillance Group, Lung Injury Response Epidemiology/Surveillance Task Force

115

Publications

9.9K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health United States Public Health Service Commissioned Officers Association Centers for Disease Control and Prevention Epidemic Intelligence Service

About

Jennifer Adjemian is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	3.1K
2	Public Health	18	18	2.8K
3	Allergy	2	2	43
4	Community Health Sciences	2	2	133
5	Social Sciences	1	1	72

Jennifer Adjemian

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020 Kathleen P. Hartnett, Aaron Kite-Powell, Jourdan DeVies, MMWR Morbidity and Mortality Weekly Report National EmergencyCovid-19 EpidemiologyUnited StatesCovid-19Clinical Epidemiology	2020	1.1K
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries Jennifer Adjemian, Kenneth N. Olivier, Amy E. Seitz, American Journal of Respiratory and Critical Care Medicine	2012	667
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12–25 Years Before and During the COVID-19 Pandemic — United States, January 2019–May 2021 Ellen Yard, Lakshmi Radhakrishnan, Michael F. Ballesteros, MMWR Morbidity and Mortality Weekly Report	2021	596
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic Kristin M. Holland, Christopher M. Jones, Alana M. Vivolo‐Kantor, JAMA Psychiatry	2021	572
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents Sameer S. Kadri, Jennifer Adjemian, Yi Ling Lai, Clinical Infectious Diseases	2018	540
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015 Kevin Winthrop, Theodore K. Marras, Jennifer Adjemian, Annals of the American Thoracic Society	2019	316
Trends in Bronchiectasis Among Medicare Beneficiaries in the United States, 2000 to 2007 Amy E. Seitz, Kenneth N. Olivier, Jennifer Adjemian, CHEST Journal Health Insurance ReformHealth EconomicsHealth PolicyMedicineAdvanced Lung Disease	2012	312
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy Elise M. N. Ferré, Stacey Rose, Sergio D. Rosenzweig, JCI Insight	2016	296
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals Sameer S. Kadri, Yi Ling Lai, Sarah Warner, The Lancet Infectious Diseases Discordant In-vitro SusceptibilitiesAntimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsHealthcare-associated Infection	2020	255
Severe Pulmonary Disease Associated with Electronic-Cigarette–Product Use — Interim Guidance Joshua G. Schier, Jonathan Meiman, Jennifer E. Layden, MMWR Morbidity and Mortality Weekly Report Tobacco CessationPulmonary CareMmwr WebsiteOccupational Health SciencesAdvanced Lung Disease	2019	241

Page 1